AmitisGen TECH Dev Group Personalized and Precision Medicine Journal 3115-7874 5 17 2020 06 01 Investigating the relationship between VEGF gene C936T-rs3025039 polymorphism and type 2 diabetes 21 24 43457 10.22034/pmj.2020.43457 EN Hadi Yari Human Genetics Division, Medical Biotechnology Department, National Institute of Genetics Engineering and Biotechnology, Tehran, Iran. Niloofar JAHANGIR SOOLTANI Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran. Mohammad Ali Saremi Personalized Medicine Research Center of AmitisGen, Tehran, Iran Journal Article 2020 07 26 Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is characterized by high blood sugar, insulin resistance, and relative lack of insulin.Diabetic retinopathy, a secondary microvascular complication of diabetes mellitus, is the leading cause of blindness. There is extensive evidence that the pathologic ocular angiogenesis in diabetic retinopathy is regulated by the vascular endothelial growth factor-A (VEGF-A).The single nucleotide polymorphism (SNP) C936T (rs3025039) of the VEGF gene has been investigated in relation to cancer, endometriosis, and age-related macular degeneration. The relationship between the rs3025039 VEGF gene polymorphism and the risk of type 2 diabetic retinopathy in 80 DT2 patients was examined. No significant association was found between polymorphism C936T and type 2 diabetes. It is recommended that this study be repeated on a larger population. https://www.pmjournal.ir/article_43457_b7be6030ef1677127676512c918087fb.pdf